Oppenheimer & Co. Inc. Has $383,000 Holdings in Equifax Inc. (NYSE:EFX)

Oppenheimer & Co. Inc. grew its position in shares of Equifax Inc. (NYSE:EFX) by 22.9% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 1,305 shares of the credit services provider’s stock after buying an additional 243 shares during the quarter. Oppenheimer & Co. Inc.’s holdings in Equifax were worth $383,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds also recently modified their holdings of EFX. Pinnacle Financial Partners Inc bought a new position in Equifax in the third quarter valued at approximately $85,000. MQS Management LLC bought a new position in shares of Equifax in the 3rd quarter valued at about $460,000. Aigen Investment Management LP bought a new stake in shares of Equifax during the 3rd quarter worth approximately $390,000. Sumitomo Mitsui Trust Group Inc. grew its position in shares of Equifax by 0.5% in the 3rd quarter. Sumitomo Mitsui Trust Group Inc. now owns 273,033 shares of the credit services provider’s stock valued at $80,233,000 after acquiring an additional 1,461 shares during the period. Finally, GSA Capital Partners LLP lifted its position in shares of Equifax by 381.9% in the third quarter. GSA Capital Partners LLP now owns 6,511 shares of the credit services provider’s stock valued at $1,913,000 after buying an additional 5,160 shares during the last quarter. Institutional investors and hedge funds own 96.20% of the company’s stock.

Equifax Stock Up 2.4 %

Shares of NYSE EFX opened at $252.92 on Friday. The stock has a market capitalization of $31.35 billion, a P/E ratio of 56.20, a P/E/G ratio of 2.31 and a beta of 1.59. Equifax Inc. has a 1 year low of $208.67 and a 1 year high of $309.63. The company has a 50-day moving average price of $278.66 and a 200-day moving average price of $267.58. The company has a debt-to-equity ratio of 0.96, a current ratio of 0.88 and a quick ratio of 0.88.

Equifax (NYSE:EFX) last announced its earnings results on Wednesday, October 16th. The credit services provider reported $1.85 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.84 by $0.01. The company had revenue of $1.44 billion for the quarter, compared to analysts’ expectations of $1.44 billion. Equifax had a return on equity of 18.56% and a net margin of 10.07%. Equifax’s quarterly revenue was up 9.3% on a year-over-year basis. During the same quarter in the previous year, the firm earned $1.76 earnings per share. On average, equities research analysts forecast that Equifax Inc. will post 7.28 EPS for the current fiscal year.

Equifax Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, December 13th. Stockholders of record on Friday, November 22nd will be paid a $0.39 dividend. The ex-dividend date of this dividend is Friday, November 22nd. This represents a $1.56 dividend on an annualized basis and a dividend yield of 0.62%. Equifax’s payout ratio is presently 34.67%.

Insider Buying and Selling at Equifax

In related news, CEO Mark W. Begor sold 58,304 shares of Equifax stock in a transaction that occurred on Friday, October 25th. The shares were sold at an average price of $270.49, for a total value of $15,770,648.96. Following the completion of the transaction, the chief executive officer now directly owns 109,183 shares in the company, valued at approximately $29,532,909.67. The trade was a 34.81 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, EVP John J. Kelley III sold 1,000 shares of the company’s stock in a transaction dated Friday, October 25th. The shares were sold at an average price of $272.92, for a total value of $272,920.00. Following the sale, the executive vice president now owns 11,269 shares in the company, valued at approximately $3,075,535.48. This represents a 8.15 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 1.57% of the company’s stock.

Analyst Upgrades and Downgrades

EFX has been the subject of several research reports. Stifel Nicolaus cut their price objective on shares of Equifax from $305.00 to $284.00 and set a “buy” rating for the company in a research report on Wednesday. Morgan Stanley increased their price target on Equifax from $250.00 to $271.00 and gave the company an “equal weight” rating in a research note on Thursday, September 12th. Oppenheimer dropped their price target on shares of Equifax from $315.00 to $286.00 and set an “outperform” rating for the company in a research note on Tuesday. BNP Paribas raised Equifax from an “underperform” rating to a “neutral” rating and set a $310.00 price objective on the stock in a research note on Thursday, September 19th. Finally, Robert W. Baird lifted their target price on shares of Equifax from $290.00 to $333.00 and gave the stock an “outperform” rating in a research note on Friday, October 18th. Four investment analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $306.74.

Equifax Company Profile

Equifax Inc operates as a data, analytics, and technology company. The company operates through three segments: Workforce Solutions, U.S. Information Solutions (USIS), and International. The Workforce Solutions segment offers services that enables customers to verify income, employment, educational history, criminal justice data, healthcare professional licensure, and sanctions of people in the United States; and employer customers with services that assist them in complying with and automating payroll-related and human resource management processes throughout the entire cycle of the employment relationship.